31 March 22 = $4.7m cash
June quarter = $4.7m - $2m expenses + 500k cash receipts + $1.1m R&D rebate = ~ $4.3m cash end of June
September quarter = $4.3m - $2m expenses + 700k cash receipts = $3m
December quarter = $3m - $2m expenses + 900k cash receipts = $1.9m
Again, the above is all approximated on what we know. Expenses will rise but the revenue/cash receipts (close to parallel now) only factors in Aus RAC.
Why do you see a CR within 2 months at these sp levels given at June 30 they'll still have, on paper, two quarters of expenses covered. Management have their flaws (investor relations) but they'll surely hold out until they can provide at least one significant business development.
Be honest, do you want a CR soon so you can get in at 3c given what's in the pipeline? Just get in now Simon and hold 2-3 years. You need a big spec stock win tiger.
Ann: Quarterly Investor Update Presentation, page-25
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 546666 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 129158 | 2 |
View Market Depth
| Last trade - 16.33pm 27/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable